Mcgraw-hills Accessmedicine
FDA Approves New Protease Inhibitor for Salavage Therapy: Darunavir (TMC114)
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Mas informaciones
Informações:
Sinopsis
HOL Grand Rounds Lectures, HOL Updates, Hursts the Heart Updates
